SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neutropenia|Breast Cancer
Interventions: DRUG: SPI-2012|DRUG: Pegfilgrastim|DRUG: Docetaxel|DRUG: Cyclophosphamide
Sponsor: Spectrum Pharmaceuticals, Inc